 |
allogeneic hematopoietic stem cell |
|---|---|
| Trade Name | Atir |
| Orphan Indication | Graft Versus Host Disease |
| USA Market Approval | USA |
| USA Designation Date | 2010-02-02 00:00:00 |
| Sponsor | Kiadis Pharma Netherlands B.V.;Entrada 231 - 234; |
| |
allogeneic hematopoietic stem cell |
|---|---|
| Trade Name | Atir |
| Orphan Indication | Graft Versus Host Disease |
| USA Market Approval | USA |
| USA Designation Date | 2010-02-02 00:00:00 |
| Sponsor | Kiadis Pharma Netherlands B.V.;Entrada 231 - 234; |